Literature DB >> 8913520

The effects of peripheral serotonin2 (5-HT2) and serotonin3 (5-HT3) receptor agonists on blood glucose levels in rats.

Y Sugimoto1, J Yamada, T Yoshikawa, K Horisaka.   

Abstract

The involvement of the peripheral serotonin2A (5-HT2A) receptor in alpha-methyl-5-HT-induced hyperglycemia was examined in rats. The 5-HT2A receptor antagonist, ketanserin, significantly inhibited alpha-methyl-5-HT-elicited hyperglycemia. Taken together with a previous report that 5-HT-induced hyperglycemia was prevented by ketanserin, it is suggested that the peripheral 5-HT2A receptor participates in glucose regulation. As alpha-methyl-5-HT increased serum insulin but did not affect glucagon levels, it is indicated that these pancreatic hormones are probably not related to alpha-methyl-5-HT-induced hyperglycemia. Moreover, the peripheral 5-HT3 receptor agonist, 2-methyl-5-HT, did not affect blood glucose, insulin or glucagon levels. Our results therefore suggest that the peripheral 5-HT3 receptor is not involved in glucose regulation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8913520     DOI: 10.1248/bpb.19.1384

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  4 in total

1.  Serotonin 5-HT(2A) Receptor Function as a Contributing Factor to Both Neuropsychiatric and Cardiovascular Diseases.

Authors:  Charles D Nichols
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-10-13

2.  Effect of sarpogrelate on altered STZ-diabetes induced cardiovascular responses to 5-hydroxytryptamine in rats.

Authors:  Dhananjay N Umrani; Dipali N Bodiwala; Ramesh K Goyal
Journal:  Mol Cell Biochem       Date:  2003-07       Impact factor: 3.396

3.  5-Hydroxytryptamine Receptor Subtypes and their Modulators with Therapeutic Potentials.

Authors:  Anand B Pithadia; Sunita M Jain
Journal:  J Clin Med Res       Date:  2009-06-21

Review 4.  Tapping into 5-HT3 Receptors to Modify Metabolic and Immune Responses.

Authors:  Helen Irving; Ilona Turek; Christine Kettle; Nor Yaakob
Journal:  Int J Mol Sci       Date:  2021-11-02       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.